Researchers solve the structure of the Zika virus helicase

Researchers solve the structure of the Zika virus helicase
From the article in Protein & Cell -- the crystal structure of Zika virus helicase: basis for antiviral drug design. Credit: Protein & Cell

A team led by researchers from Tianjin University (P.R. China) has solved the structure of the Zika virus helicase, which is a key target for antiviral development. The research is published in Springer's journal Protein & Cell.

The Zika virus can cause microcephaly and other severe birth defects. However, as there are currently no effective vaccines or therapies available to contain ZIKV infection, ZIKV remains a significant challenge to public health.

All viruses seem to need a helicase for replication. The Zika virus helicase is a motor enzyme which can convert energy from nucleoside triphosphate to unwind double stranded nucleic acids. This is an essential step for viral replication. By targeting Zika virus helicase with small-molecule inhibitors, it might be possible to stop viral and prevent disease. The scientists have successfully obtained an image at 1.8 angstroms of this viral enzyme. An angstrom is one ten-billionth (10-10) of a meter. This high-resolution image of the Zika virus key enzyme will help scientists develop drugs to treat the Zika disease.


Explore further

Zika virus: Five things to know

More information: Hongliang Tian et al, The crystal structure of Zika virus helicase: basis for antiviral drug design, Protein & Cell (2016). DOI: 10.1007/s13238-016-0275-4
Provided by Springer
Citation: Researchers solve the structure of the Zika virus helicase (2016, May 20) retrieved 23 August 2019 from https://medicalxpress.com/news/2016-05-zika-virus-helicase.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more